Advances in Subcutaneous Delivery Systems of Biomacromolecular Agents for Diabetes Treatment

Diabetes mellitus is a major threat to human health. Both its incidence and prevalence have been rising steadily over the past few decades. Biomacromolecular agents such as insulin and glucagon-like peptide 1 receptor agonists are commonly used hypoglycemic drugs that play important roles in the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chen, Wan, Long, Luo, Jie, Jiang, Mingyan, Wang, Keke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898203/
https://www.ncbi.nlm.nih.gov/pubmed/33628020
http://dx.doi.org/10.2147/IJN.S283416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898203/
https://www.ncbi.nlm.nih.gov/pubmed/33628020
http://dx.doi.org/10.2147/IJN.S283416

Ejemplares similares